Taysha Gene Therapies, Inc.

B Group, Inc. TSHA
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/17/2026
Shares
1,800,556
Value ($000)
9,903
Weight
7.3%
2025 Q2 - 2025 Q4 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).